Related Experiment Videos
[A case of suspected liver dysfunction induced by sevoflurane anesthesia]
K Watanabe1, S Hatakenaka, K Ikemune
1Department of Anesthesiology, Ehime Prefecture Imabari Hospital.
Masui. the Japanese Journal of Anesthesiology
|June 1, 1993
Summary
This case study highlights potential toxic liver dysfunction in an infant following sevoflurane anesthesia. Elevated liver enzymes normalized within two months, suggesting a non-allergic, sevoflurane-induced hepatotoxicity.
Area of Science:
- Anesthesiology
- Pediatric Hepatology
- Toxicology
Background:
- Sevoflurane is a widely used inhalational anesthetic in pediatric surgery.
- Liver dysfunction is a rare but serious complication associated with general anesthesia.
- Distinguishing between allergic and toxic reactions to anesthetic agents is crucial for patient management.
Observation:
- A 30-day-old male infant developed symptoms of liver dysfunction, including vomiting and anorexia, two days post-inguinal herniorrhaphy under sevoflurane anesthesia.
- Significant elevations in liver enzymes (GOT, GPT, LDH) were observed, peaking 12-16 days after surgery.
- Viral hepatitis markers, blood transfusions, and antibiotic use were ruled out as causes.
Findings:
- The infant's clinical symptoms and laboratory values indicating liver dysfunction gradually resolved within two months.
- A lymphocyte stimulation test for sevoflurane allergy was negative.
- The pattern of liver enzyme elevation and clinical course suggested a toxic, rather than allergic, reaction to sevoflurane.
Implications:
- This case suggests that sevoflurane can cause direct toxic liver injury in infants, independent of an allergic mechanism.
- Further investigation into the mechanisms of sevoflurane-induced hepatotoxicity is warranted.
- Clinicians should consider sevoflurane toxicity in the differential diagnosis of unexplained liver dysfunction in pediatric patients post-anesthesia.